K770451

Substantially Equivalent

ALBUMIN PROCEDURE, TEKPOINT BROMCRESOL

Applicant: Icn Pharmaceuticals, Inc.
Product code: CIX
Advisory panel: Clinical Chemistry
Date received: 1977-03-08
Decision date: 1977-05-03
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Orangeburg, NY, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.